Pooled humoral immunogenicity for recombinant herpes zoster vaccine compared with control arm at end of follow-up period.

Pooled humoral immunogenicity for recombinant herpes zoster vaccine compared with control arm at end of follow-up period.

<p>Long-term data on humoral immunogenicity with the vaccine and control arms.</p> <p>(TIF)</p>

Saved in:

Bibliographic Details
Main Author:	Fawziah Marra (269802) (author)
Other Authors:	Michael Yip (20324056) (author), Jacquelyn J. Cragg (9906848) (author), Nirma Khatri Vadlamudi (9443783) (author)
Published:	2024
Subjects:	Medicine Biotechnology Evolutionary Biology Immunology Cancer Science Policy Infectious Diseases systemic adverse events serious adverse events randomized clinical trials preexisting autoimmune diseases pooled using random moderate heterogeneity across herpes zoster infection herpes zoster across recombinant zoster vaccine evaluating rzv compared herpes zoster xlink "> systematic search systematic review rzv reduces rzv reduced routinely offered past malignancy october 2023 level characteristics last dose january 1984 immunocompromised adults immune responses data sources cochrane central advisory committee 44 ), 07 ).
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Cannot write session to /tmp/vufind_sessions/sess_uh0el9tavortkt623skd5qgi8a